• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10617
Device Problems Device Dislodged or Dislocated (2923); Material Integrity Problem (2978); Migration (4003)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/28/2022
Event Type  malfunction  
Event Description
It was reported that stent was not visible after implanted.The target lesion was located in the ostial right coronary artery.A 2.75 x 12 synergy ii drug-eluting stent was advanced and deployed for treatment.Post-dilation was performed with 3.0x8mm nc balloon; however, the stent was not visible when the wire was removed and picture was taken.The physician proceeded to re wire and another 3.0 x 8mm synergy stent was deployed and post dilated.After that, a full body scan was performed with no sign of the stent.The procedure was completed with a different 3.0x8mm synergy stent.No patient complications were reported and the patient status was stable.
 
Manufacturer Narrative
H2: ar code correction.
 
Event Description
It was reported that stent was not visible after implanted.The target lesion was located in the ostial right coronary artery.A 2.75 x 12 synergy ii drug-eluting stent was advanced and deployed for treatment.A post-dilation was performed with 3.0x8mm nc balloon; however, the stent was not visible when the wire was removed and picture was taken.The physician proceeded to re wire and another 3.0 x 8mm synergy stent was deployed and post dilated with a 3.0 x 8 mm nc balloon.After that, a full body scan was performed with no sign of the stent.The procedure was completed with a different 3.0x8mm synergy stent.No patient complications were reported and the patient status was stable.It was further reported that the second stent, a 3.0 x 8mm synergy des, was successfullydeployed and visible on cine.The 2.75x12mm synergy des was not visible as it potentially migrated upon inflation.The staff confirmed all materials used were checked and a stent was nowhere to be found.
 
Event Description
It was reported that stent was not visible after implanted.The target lesion was located in the ostial right coronary artery.A 2.75 x 12 synergy ii drug-eluting stent was advanced and deployed for treatment.A post-dilation was performed with 3.0x8mm nc balloon; however, the stent was not visible when the wire was removed and picture was taken.The physician proceeded to re wire and another 3.0 x 8mm synergy stent was deployed and post dilated with a 3.0 x 8 mm nc balloon.After that, a full body scan was performed with no sign of the stent.The procedure was completed with a different 3.0x8mm synergy stent.No patient complications were reported and the patient status was stable.It was further reported that the second stent a 3.0 x 8mm synergy stent was deployed as the initial stent went missing upon inflation.Furthermore, the 2.75x12mm synergy stent was not visible as it perhaps traveled inside the patient or may have also been pulled back in the guide catheter.The staff confirmed they checked all materials used and stent was nowhere to be found.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key13686443
MDR Text Key286774610
Report Number2134265-2022-02511
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeAS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 03/31/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/08/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/15/2023
Device Model Number10617
Device Catalogue Number10617
Device Lot Number0027561669
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/14/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/15/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-